2024年12月31日 · SIGA is a leader in global health, developing medicines to prevent and treat emerging infectious diseases with high unmet medical needs. Infectious diseases pose an imminent and severe threat to global health that cannot be …

SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.

Find the latest SIGA Technologies, Inc. (SIGA) stock quote, history, news and other vital information to help you with your stock trading and investing.

2025年3月11日 · SIGA’s strategy is focused on delivering long-term shareholder value. To achieve this, the Company has concentrated its efforts in four pivotal areas to drive growth.

SIGA is a leader in global health, developing medicines to prevent and treat emerging infectious diseases with high unmet medical needs. Infectious diseases pose an imminent and severe threat to global health that cannot be adequately addressed with vaccines alone.

2025年3月28日 · SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for medical needs and biothreats.

2025年4月2日 · Get a real-time SIGA Technologies, Inc. (SIGA) stock price with an overview of financials, statistics, forecasts, charts and more.